Search results
Results from the WOW.Com Content Network
Tetryzoline , [3] also known as tetrahydrozoline, is a drug used in some over-the-counter eye drops and nasal sprays. Tetryzoline was patented in 1954, and came into medical use in 1959. Tetryzoline was patented in 1954, and came into medical use in 1959.
SGLT2 inhibitors are used in the treatment of type 2 diabetes. Apart from blood sugar control, gliflozins have been shown to provide significant cardiovascular benefit in people with type 2 diabetes. [2] [3] As of 2014, several medications of this class had been approved or were under development. [4]
Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.
The study found that while both were linked to an increased chance of hypoglycemia (dangerously low blood sugar) in the short term, people taking sulfonylureas after 5 or more years were roughly ...
Symptoms and effects can be mild, moderate or severe, depending on how low the glucose falls and a variety of other factors. It is rare but possible for diabetic hypoglycemia to result in brain damage or death. Indeed, an estimated 2–4% of deaths of people with type 1 diabetes mellitus have been attributed to hypoglycemia. [2] [3]
See hypoglycemia for more on effects, recovery, and risks. Further therapy and prevention depends upon the specific cause. Most hypoglycemia due to excessive insulin occurs in people who take insulin for type 1 diabetes. Management of this hypoglycemia is sugar or starch by mouth (or in severe cases, an injection of glucagon or intravenous ...
Glucose-elevating agents are medications used to treat hypoglycemia (low blood sugar) by raising blood glucose.In diabetics, hypoglycemia can occur as a result of too much insulin or antidiabetic medication, insufficient food intake, or sudden increase in physical activity or exercise.
(Reuters) -Rezolute Inc said on Monday the U.S. Food and Drug Administration had lifted its partial clinical hold on a late-stage study testing the company's treatment for low blood sugar, sending ...